<DOC>
	<DOC>NCT02237534</DOC>
	<brief_summary>The purpose of this study is to compare the effect of lanthanum carbonate and calcium carbonate on the progression of coronary calcification and vascular endothelial dysfunction.</brief_summary>
	<brief_title>Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Bone Diseases, Metabolic</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>Hyperphosphatemia (For patients without calcium carbonate, ≥4.5 mg/dL) (For patients with calcium carbonate, ≥4.0 mg/dL) With written informed consent History of cardiac surgery With coronary artery stent Polycystic kidney disease Hypothyroidism On treatment with lanthanum carbonate History of admission within 3 months History of ileus Severe liver dysfunction Severe gastrointestinal dysfunction Allergy to lanthanum carbonate or calcium carbonate Pregnant or breastfeeding women Judged as ineligible by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Lanthanum</keyword>
	<keyword>Calcium Carbonate</keyword>
	<keyword>Vascular Calcification</keyword>
</DOC>